UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Circulating Glycan Monosaccharide Composite-Based Biomarker Diagnoses Colorectal Cancer at Early Stages and Predicts Prognosis

Frontiers in oncology, 2022-04, Vol.12, p.852044-852044

2022

Volltextzugriff (PDF)

Advances in research on the anti-tumor mechanism of Astragalus polysaccharides

Frontiers in oncology, 2024-03, Vol.14, p.1334915-1334915

2024

Volltextzugriff (PDF)

Chimeric antigen receptor T-cell therapy for T-ALL and AML

Frontiers in oncology, 2022-11, Vol.12, p.967754-967754

2022

Volltextzugriff (PDF)

A novel ferroptosis-related gene signature for predicting prognosis in multiple myeloma

Frontiers in oncology, 2023-02, Vol.13, p.999688-999688

2023

Volltextzugriff (PDF)

Identification and Development of Subtypes With Poor Prognosis in Pan-Gynecological Cancer Based on Gene Expression in the Glycolysis-Cholesterol Synthesis Axis

Frontiers in oncology, 2021-03, Vol.11, p.636565-636565

2021

Volltextzugriff (PDF)

Machine learning models based on quantitative dynamic contrast-enhanced MRI parameters assess the expression levels of CD3 + , CD4 + , and CD8 + tumor-infiltrating lymphocytes in advanced gastric carcinoma

Frontiers in oncology, 2024-03, Vol.14, p.1365550-1365550

2024

Volltextzugriff (PDF)

Construction of a Nomogram Model for Predicting Peritoneal Dissemination in Gastric Cancer Based on Clinicopathologic Features and Preoperative Serum Tumor Markers

Frontiers in oncology, 2022-06, Vol.12, p.844786-844786

2022

Volltextzugriff (PDF)

POLE and Mismatch Repair Status, Checkpoint Proteins and Tumor-Infiltrating Lymphocytes in Combination, and Tumor Differentiation: Identify Endometrial Cancers for Immunotherapy

Frontiers in oncology, 2021-03, Vol.11, p.640018-640018

2021

Volltextzugriff (PDF)

Potential of the Non-Contrast-Enhanced Chest CT Radiomics to Distinguish Molecular Subtypes of Breast Cancer: A Retrospective Study

Frontiers in oncology, 2022-03, Vol.12, p.848726-848726

2022

Volltextzugriff (PDF)

Computed Tomography-Based Radiomics in Predicting T Stage and Length of Esophageal Squamous Cell Carcinoma

Frontiers in oncology, 2021-10, Vol.11, p.722961-722961

2021

Volltextzugriff (PDF)

Knockdown of LMTK3 in the Endometrioid Adenocarcinoma Cell Line Ishikawa: Inhibition of Growth and Estrogen Receptor α

Frontiers in oncology, 2021-10, Vol.11, p.692282-692282

2021

Volltextzugriff (PDF)

DNA Damage Repair Gene Mutations Are Indicative of a Favorable Prognosis in Colorectal Cancer Treated With Immune Checkpoint Inhibitors

Frontiers in oncology, 2021-02, Vol.10, p.549777

2021

Volltextzugriff (PDF)

Integrative dissection of 5-hydroxytryptamine receptors-related signature in the prognosis and immune microenvironment of breast cancer

Frontiers in oncology, 2023-09, Vol.13, p.1147189-1147189

2023

Volltextzugriff (PDF)

Retrospective, multicenter study of surgical treatment for carotid body tumors with or without preoperative embolization

Frontiers in oncology, 2023-03, Vol.13, p.1123430-1123430

2023

Volltextzugriff (PDF)

Expression and molecular regulation of non-coding RNAs in HPV-positive head and neck squamous cell carcinoma

Frontiers in oncology, 2023-03, Vol.13, p.1122982-1122982

2023

Volltextzugriff (PDF)

The novel high-affinity humanized antibody IMM40H targets CD70, eliminates tumors via Fc-mediated effector functions, and interrupts CD70/CD27 signaling

Frontiers in oncology, 2023-10, Vol.13, p.1240061-1240061

2023

Volltextzugriff (PDF)

Necroptosis-related lncRNAs: Combination of bulk and single-cell sequencing reveals immune landscape alteration and a novel prognosis stratification approach in lung adenocarcinoma

Frontiers in oncology, 2022-10, Vol.12, p.1010976-1010976

2022

Volltextzugriff (PDF)

Integrative Analysis of Complement System to Prognosis and Immune Infiltrating in Colon Cancer and Gastric Cancer

Frontiers in oncology, 2021-02, Vol.10, p.553297-553297

2021

Volltextzugriff (PDF)

Case report: Post-therapeutic laryngeal carcinoma patient possessing a high ratio of aneuploid CTECs to CTCs rapidly developed de novo malignancy in pancreas

Frontiers in oncology, 2022-09, Vol.12

2022

Volltextzugriff (PDF)

Risk score constructed with neutrophil extracellular traps-related genes predicts prognosis and immune microenvironment in multiple myeloma

Frontiers in oncology, 2024, Vol.14, p.1365460

2024

Volltextzugriff (PDF)

The Genomic Characteristics of ALK Fusion Positive Tumors in Chinese NSCLC Patients

Frontiers in oncology, 2020-05, Vol.10, p.726-726

2020

Volltextzugriff (PDF)

Potential candidates for liver resection in liver-confined advanced HCC: a Chinese multicenter observational study

Frontiers in oncology, 2023-06, Vol.13, p.1170923-1170923

2023

Volltextzugriff (PDF)

DCE-MRI radiomics models predicting the expression of radioresistant-related factors of LRP-1 and survivin in locally advanced rectal cancer

Frontiers in oncology, 2022-08, Vol.12, p.881341-881341

2022

Volltextzugriff (PDF)

A Prognostic Model of Non-Small Cell Lung Cancer With a Radiomics Nomogram in an Eastern Chinese Population

Frontiers in oncology, 2022-06, Vol.12, p.816766-816766

2022

Volltextzugriff (PDF)

Identify optimal HAP series scores for unresectable HCC patients undergoing TACE plus sorafenib: A Chinese multicenter observational study

Frontiers in oncology, 2023-01, Vol.12, p.983554-983554

2023

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Full Collection 2018

ThemaChemistry

Zeitschrift / SerieFrontiers In Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

Oncology
(30)
Life Sciences & Biomedicine
(29)
Science & Technology
(29)
Prognosis
(5)
Hepatocellular Carcinoma
(3)
Proliferation
(3)
Apoptosis
(2)
Breast Cancer
(2)
Cisplatin
(2)
Colorectal Cancer
(2)
Drug Sensitivity
(2)
Dynamic Contrast-Enhanced Magnetic Resonance Imaging
(2)
Esophageal Cancer
(2)
Gastric Cancer
(2)
Immune Infiltration
(2)
Immunotherapy
(2)
Machine Learning
(2)
Mir-135b-5p
(2)
Multiple Myeloma
(2)
Nomogram
(2)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

IngentaConnect Journals
(30)
EZB-FREE-00999 freely available EZB journals
(30)
IngentaConnect
(30)

Menü

Weitere Dienste

Einstellungen

Circulating Glycan Monosaccharide Composite-Based Biomarker Diagnoses Colorectal Cancer at Early Stages and Predicts Prognosis

Advances in research on the anti-tumor mechanism of Astragalus polysaccharides

Chimeric antigen receptor T-cell therapy for T-ALL and AML

A novel ferroptosis-related gene signature for predicting prognosis in multiple myeloma

Identification and Development of Subtypes With Poor Prognosis in Pan-Gynecological Cancer Based on Gene Expression in the Glycolysis-Cholesterol Synthesis Axis

Machine learning models based on quantitative dynamic contrast-enhanced MRI parameters assess the expression levels of CD3 + , CD4 + , and CD8 + tumor-infiltrating lymphocytes in advanced gastric carcinoma

Construction of a Nomogram Model for Predicting Peritoneal Dissemination in Gastric Cancer Based on Clinicopathologic Features and Preoperative Serum Tumor Markers

POLE and Mismatch Repair Status, Checkpoint Proteins and Tumor-Infiltrating Lymphocytes in Combination, and Tumor Differentiation: Identify Endometrial Cancers for Immunotherapy

Potential of the Non-Contrast-Enhanced Chest CT Radiomics to Distinguish Molecular Subtypes of Breast Cancer: A Retrospective Study

Computed Tomography-Based Radiomics in Predicting T Stage and Length of Esophageal Squamous Cell Carcinoma

Knockdown of LMTK3 in the Endometrioid Adenocarcinoma Cell Line Ishikawa: Inhibition of Growth and Estrogen Receptor α

DNA Damage Repair Gene Mutations Are Indicative of a Favorable Prognosis in Colorectal Cancer Treated With Immune Checkpoint Inhibitors

Integrative dissection of 5-hydroxytryptamine receptors-related signature in the prognosis and immune microenvironment of breast cancer

Retrospective, multicenter study of surgical treatment for carotid body tumors with or without preoperative embolization

Expression and molecular regulation of non-coding RNAs in HPV-positive head and neck squamous cell carcinoma

The novel high-affinity humanized antibody IMM40H targets CD70, eliminates tumors via Fc-mediated effector functions, and interrupts CD70/CD27 signaling

Necroptosis-related lncRNAs: Combination of bulk and single-cell sequencing reveals immune landscape alteration and a novel prognosis stratification approach in lung adenocarcinoma

Integrative Analysis of Complement System to Prognosis and Immune Infiltrating in Colon Cancer and Gastric Cancer

Case report: Post-therapeutic laryngeal carcinoma patient possessing a high ratio of aneuploid CTECs to CTCs rapidly developed de novo malignancy in pancreas

Risk score constructed with neutrophil extracellular traps-related genes predicts prognosis and immune microenvironment in multiple myeloma

The Genomic Characteristics of ALK Fusion Positive Tumors in Chinese NSCLC Patients

Potential candidates for liver resection in liver-confined advanced HCC: a Chinese multicenter observational study

DCE-MRI radiomics models predicting the expression of radioresistant-related factors of LRP-1 and survivin in locally advanced rectal cancer

A Prognostic Model of Non-Small Cell Lung Cancer With a Radiomics Nomogram in an Eastern Chinese Population

Identify optimal HAP series scores for unresectable HCC patients undergoing TACE plus sorafenib: A Chinese multicenter observational study

Aktive Filter

Suchergebnisse filtern